◇◇◆◇◇◆◇◇◆◇◇◆◇◇◆

Click!!!  腎生理ブログは

コチラ

 ◇◇◆◇◇◆◇◇◆◇◇◆◇◇◆

 

 

○●論文●○

~近年発表された英文論文をご紹介致します。~

 

 

2011

 

Endogenous hydrogen peroxide up-regulates the expression of nitric oxide synthase in the kidney of SHR.

Cao Pengyu, Ito Osamu, Guo Qi, Ito Daisuke, Muroya Yoshikazu, Rong Rong, Mori Takefumi, Ito Sadayoshi, Kohzuki Masahiro.

J Hypertens. 2011 Jun;29(6):1167-74

 

Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama Study.

Michihiro Satoh, Masahiro Kikuya, Takayoshi Ohkubo, Takefumi Mori, Hirohito Metoki, Takanao Hashimoto, Azusa Hara, Megumi T. Utsugi, Tkuo Hirose, Taku Obara, Ryusuke Inoue, Kei Asayama, Atsuhiro Kanno, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, and Yutaka Imai

Jounal of Hypertension 2011 Oct.29(10):1940-7

 

 

 

Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats.

Qi Guo, Takefumi Mori, Yue Jiang, Chunyan Hu, Yusuke Osaki, Yoshimi Yoneki, Takashi Nakamichi, Susumu Ogaawa, Hiroshi Sato, Sadayoshi Ito.

Hypertension Research 2012 Jan;35(1):48-54.

 

 

 


1.        Cao Pengyu, Ito Osamu, Guo Qi, Ito Daisuke, Muroya Yoshikazu, Rong Rong, Mori Takefumi, Ito, Sadayoshi, Kohzuki Masahiro. Endogenous hydrogen peroxide up-regulates the expression of nitric oxide synthase in the kidney of SHR. J Hypertens. 2011 Jun;29(6):1167-74.

2.        Haruki Momma, Kaijun Niu, Yoritoshi Kobayashi, Lei Guen, Mika Sato, Hui Guo, Masahiko Chujo, Atsushi Otomo, Cui Yufei, Hiroko Tadaura, Tatsunori Saito, Takefumi Mori, Toshio Miyata, RyoichiNagatomi. Skin advanced glycation end product accumulation and muscle strength among adult men.  European Journal of Applied Physiology 2011 Jul;111(7):1545-52.

3.        Michihiro Satoh, Masahiro Kikuya, Takayoshi Ohkubo, Takefumi Mori, Hirohito Metoki, Takanao Hashimoto, Azusa Hara, Megumi T. Utsugi, Takuo Hirose, Taku Obara, Ryusuke Inoue, Kei Asayama, Atsuhiro Kanno, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, and Yutaka Imai Aldosterone-to-renin ratio and nocturnal blood pressure decline in a general population: the Ohasama Study. Journal of Hypertension 2011 Oct;29(10):1940-7. 

4.        Qi Guo, Takefumi Mori, Yue Jiang, Chunyan Hu, Yusuke Ohsaki, Yoshimi Yoneki,

Takashi Nakamichi, Susumu Ogawa, Hiroshi Sato, Sadayoshi Ito. Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats.  Hypertension Research 2012 Jan;35(1):48-54.  

 

2010

Significance of Advanced Glycation End Products in Aging-Related Disease.

Ryoji Nagai, Takefumi Mori, Yasuhiko Yamammoto, Yuichi Kaiji, Yoshikazu Yonei.

Anti-Aging Medicine.2010;7(10):112-119.

 

Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure.

Takuo Hirose, Kazuhito Totsune, Nobuyuki Mori, Takefumi Mori, Ryo Morimoto, Hirohito Metoki, Kei Asayama, Masahiro Kikuya, Takayoshi Ohkubo, Masahiro Kohzuki, Kazuhiro Takahashi, Yutaka Imai.

Am J Physiol Renal Physiol.2010;299(1):F128-34.

 

Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin Ⅱblockabe.

Genei Ihara, Hideyasu Kiyomoto, Hiroyuki Kobori, Yukiko Nagai, Naro Ohashi, Hirofumi Hitomi, Daisuke Nakano, Nicolas Pelisch, Taiga Hara, Takefumi Mori, Sadayoshi Ito, Masakazu Kohno, Akira Nishiyama.

J Hypertens.2010;(11):2289-98.

Methylglyoxal is a predictor in type 2 diabetic patients of intima-media thickening and elevation of blood pressure.

Susumu Ogawa, Keisuke Nakayama, Masaaki Nakayama, Takefumi Mori, Masato Matsushima, Masashi Okamura, Miho Senda, Kazuhiro Nako, Toshio Miyata, Sadayoshi Ito.

Hypertension.2010;56(3):471-6.

 

A novel clinical biomarker for myeloperoxidase-antineutrophil cytoplasmic antibody associated glomerulonephritis.

Takefumi Mori, Hirofumi Hitomi, Takashi Nakamichi, Toshio Miyata, Hiroshi Sato, Sadayoshi Ito.

Clin Exp Pharmacol Physiol.2010;37(9):877-8.

 

Aldosterone-to-Renin Ratio and Home Blood Pressure in Subjects with Higher and Lower Sodium Intake:The Ohasama Study.

Michihiro Satoh, Masahiro Kikuya, Azusa Hara, Takayoshi Ohkubo, Takefumi Mori, Hirohito Metoki, Megumi T Utsuigi, Takuo Hirose, Taku Obara, Ryusuke Inoue, Kei Asayama, Kazuhito Totsune, Haruhisa Hoshi, Hiroshi Satoh, Yutaka Imai.

Hypertens Res.2010 in Press

 

Intake of water with high levels of dissolved hydrogen (H2) suppresses inchemia-induced cardio-renal injury in Dahl salt sensitive rats.

Wan-Jun Zhu, Masaaki Nakayama, Takefumi Mori, Keisuke Nakayama, Junishiro Katoh, Yaeko Murata, Toshinobu Sat, Shigeru Kabayama, Sadayoshi Ito.

Nephrol Dial Transplant 2011 in Press.

 

Skin advanced glycation end product accumulation and muscle strength among adult men.

Haruki Momma, Kaijun Niu, Yoritoshi Kobayashi, Lei Guen, Mika Sato, Hui Guo, Masahiko Chujo, Atsushi Otomo, Cui Yufei, Hiroko Tadaura, Tatsunori Saito, Takefumi Mori, Toshio Miyata, Ryoichi Nagatomi.

European Journal of Applied Physiology in Press.

2009

Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production.

Jin C, Hu C, Polichnowski A, Mori T, Skelton M, Ito S, Cowley AW Jr.

Hypertension. 2009 Jun;53(6):1048-53. Epub 2009 May 11

 

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy.

Ogawa S, Kobori H, Ohashi N, Urushihara M, Nishiyama A, Mori T, Ishizuka T, Nako K, Ito S.

Biomark Insights. 2009 Jun 23;4:97-102.

 

Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats.

Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, Sun Y, Hosoya T, Kawamata A, Ogawa S, Nakayama M, Miyata T, Ito S.

J Hypertens. 2009 Aug;27(8):1664-71.

 

Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats.

Endo S, Mori T, Yoneki Y, Nakamichi T, Hosoya T, Ogawa S, Tokudome G, Hosoya T, Miyata T, Ito S.

Hypertens Res. 2009 Jun;32(6):513-9. Epub 2009 May 1.

 

Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies.

Ishizuka T, Ogawa S, Mori T, Nako K, Nakamichi T, Oka Y, Ito S.

Diabetes Res Clin Pract. 2009 May;84(2):e21-3. Epub 2009 Mar 27.

 

Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk.

Ito S, Nagasawa T, Abe M, Mori T.

Hypertens Res. 2009 Feb;32(2):115-21. Epub 2009 Jan 16. Review.

 

2008

High perfusion pressure accelerates renal injury in salt-sensitive hypertension.

Mori T, Polichnowski A, Glocka P, Kaldunski M, Ohsaki Y, Liang M, Cowley AW Jr.

J Am Soc Nephrol. 2008 Aug;19(8):1472-82. Epub 2008 Apr 16.

 

Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy.

Ogawa S, Mori T, Nako K, Ito S.

Hypertens Res. 2008 Jun;31(6):1147-55.

 

Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.

Ogawa S, Mori T, Nako K, Ishizuka T, Ito S.

Clin J Am Soc Nephrol. 2008 Mar;3(2):362-8. Epub 2008 Jan 30.

 

2007

Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk.

Mori T, O'Connor PM, Abe M, Cowley AW Jr.

Hypertension. 2007 Jun;49(6):1336-41. Epub 2007 Apr 30.

 

Effects of monotherapy of temocapril or candesartan with dose increments or combination therapy with both drugs on the suppression of diabetic nephropathy.

Ogawa S, Takeuchi K, Mori T, Nako K, Tsubono Y, Ito S.

Hypertens Res. 2007 Apr;30(4):325-34.

 

2006

Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.

Mori T, Cowley AW Jr, Ito S.

J Pharmacol Sci. 2006 Jan;100(1):2-8. Epub 2006 Jan 11. Review.

 

Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.

Ogawa S, Takeuchi K, Mori T, Nako K, Ito S.

Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):477-9.

 

Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy.

Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S.

Hypertension. 2006 Apr;47(4):699-705. Epub 2006 Feb 27.

 

Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.

Mori T, Cowley AW Jr, Ito S.

J Pharmacol Sci. 2006 Jan;100(1):2-8. Epub 2006 Jan 11. Review.

 

2005

[Perspectives of vasopressin receptor antagonists]

Mori T, Ito S.

Nippon Rinsho. 2005 Mar;63 Suppl 3:525-9. Review. Japanese. No abstract available

 

 

HOME